Abstract WHO/UNICEF estimates for HPV vaccination coverage from 2010 to 2019 are
analyzed against the backdrop of the 90% coverage target for HPV vaccination by 2030 set …

Human papillomavirus (HPV) infection is responsible for many cancers in both women and
men. Cervical cancer, caused by HPV, is the fourth most common cancer among women …

Men should not be overlooked in research on human papillomavirus (HPV) and its
associated genital diseases. This is because men infected with HPV are not only at higher …

With major advances in understanding the infectious etiology of cervical cancer, preventive
medicine has obtained highly promising new tools. Human papillomavirus (HPV) vaccines …

Human papillomavirus (HPV) infection is responsible for approximately 5% of all cancers
and is associated with 30% of all pathogen-related cancers. Cervical cancer is the third most …

The long-term effect of population-level human papillomavirus (HPV) vaccination on the viral
ecology of the untargeted HPVs is poorly understood. We performed an 8-year follow-up of …

Vaccines against human papillomavirus (HPV) are available in Europe since 2006. They
have been highly effective in preventing infection and disease caused by the vaccine types …

Simple Summary Head and neck cancers of the oropharyngeal subsite can be driven by the
human papillomavirus (HPV). In countries such as the United States, the incidence of HPV …

Background Incidence of cervical cancer has been reduced by organized screening while
for vaginal and vulvar cancers no systematic screening has been implemented. All these …

Vaginal flora plays a crucial role in human papillomavirus (HPV) infection and progression
to cancer. To reveal a role of the vaginal flora in HPV persistence and clearance, 90 patients …